29 June 2024
Manuscript: Circulating Tumor Cells as Biomarkers for Relapse Detection in Rectal Cancer with Liver Metastasis: Insights from a Case Report
Nirmal Raut, Atul Bharde, Sreeja Jayant, Gaurishankar Aland, Aravindan Vasudevan, Jayant Khandare
In this case report we demonstrate the utility of CTC as a sensitive marker to detect MRD. CTCs play a crucial role in the context of MRD in colorectal cancer, offering a valuable biomarker for prognosis,
treatment monitoring, and early detection of recurrence. Despite the challenges in their clinical application, CTCs hold great potential to transform the management of CRC by enabling more personalized and effective treatment approaches. As technology advances, the integration
of CTC analysis into routine clinical practice may become a reality, significantly improving outcomes for patients with colorectal cancer.
Never Miss a Breakthrough.
Get the latest news and innovations from OncoDiscover delivered straight to your inbox.
Early detection is half the battle won.
Book a Test
Simply book a CTC Test online or over a phone call and schedule a visit by our registered phlebotomists.
Sample Collection
Upon booking the CTC Test, one of our registered phlebotomists shall visit and collect 5 ml of patient’s blood sample.
Receive Report
A set of diagnostics will be run on the patient’s blood sample and the report shall be provided in 7 working days upon receipt of sample on site.